Law channel feed – Endpoints News

Law channel feed

Protecting its megablockbuster, Janssen challenges Amgen's Stelara biosimilar ahead of planned 2023 launch

3 years ago

Merck sues Johns Hopkins for licensing Keytruda patents in secret and in conflict with research collaboration

3 years ago

A Supreme Court chill across biosimilar 'skinny' labels could halt billions in Medicare savings

3 years ago

US seeks jail time for co-CEO of New England compounding center after deadly 2012 fungal outbreak

3 years ago

Court KOs REMS-related patent listing for Jazz narcolepsy drug

3 years ago

Anti-abortion groups file suit against FDA in Texas, demands agency revoke approval for abortion pill

3 years ago

Pharma foe Bernie Sanders to take over leadership of Senate health committee

3 years ago

Drugmaker fined by Spanish regulators $10M for 'excessive price' of rare disease drug

3 years ago

Walmart is next in line on national opioid settlement, paying $3B+ for its role in epidemic

3 years ago

Allergan and Merz settle more Alzheimer's drug pay-for-delay allegations for $54M

3 years ago

SEC snatches Viatris information chief in $8M insider trading scheme via cash payments in India

3 years ago

Pharma-backed charity sues HHS to help pay for seniors' pricey cancer drugs

3 years ago

FTC calls out Jazz Pharma's abuse of FDA Orange Book listing process

3 years ago

Teva wins $175M settlement after jury orders Eli Lilly to pay up on patent infringement suit

3 years ago

Supreme Court tosses Bristol Myers' bid to revive $1.2B CAR-T case against Gilead

3 years ago

SCOTUS to review Amgen-Sanofi patent battle as a proxy for how narrowly pharma patents will need to be written

3 years ago

Teva reaches $523M agreement with New York in latest opioid-related settlement

3 years ago

With drug price negotiations in the books, Dems turn to launch prices as the next challenge

3 years ago

CVS, Walgreens and Walmart reach nearly $12B settlement over opioid epidemic

3 years ago

For months Biden has touted his win over pharma in the election lead-up. Will it help?

3 years ago

AbbVie puts up fight against Orilissa generics from Sandoz, Teva and others

3 years ago

Gilead finds 'critical holes' in the government's HIV patent case against it

3 years ago

In next step of opioid saga, McKinsey reaches proposed agreement with school districts and local governments

3 years ago

Alnylam blames the Inflation Reduction Act for a PhIII cut — would it have sold enough for negotiations?

3 years ago

First page Previous page 25 26 272829 30 31 Next page Last page